Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylprednisolone in total hip-arthroplasty
NCT02542592Phase 3Completed
- Sponsor
- Rigshospitalet
- Start
- Sep 2015
- Primary completion
- Jan 2017
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in osteoarthritis (OA) comparing Methylprednisolone with Placebo (2 arms). Primary endpoint: Signal transducer and activator of transcription 3 at 48 hours. Started Sep 2015; status: completed.
02
Drugs
methylprednisolone injection
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT02542592.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02542592.